It’s seems like no matter how much elite try’s, their upside is limited. They should should sell the company. Problem is no one will pay what Nasrat wants as they will view his share count as extremely greedy.
Just my opinion.
Nasrat should return half the shares. He made enough off Mikah already. Again, just my opinion
I hate to say it, but now they are free to charge more for their product, what ever the price will bare, in a free competitive environment, and when people complain, just blame it on the FDA/DEA.